Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 61
Filtrar
1.
Future Med Chem ; 13(17): 1465-1474, 2021 09.
Artigo em Inglês | MEDLINE | ID: mdl-34251270

RESUMO

Background: Clinically, corticosteroids are used mainly for their immune-modulatory properties but are also known to influence mood. Despite evidence of a role in regulating tryptophan hydroxylases (TPH), key enzymes in serotonin biosynthesis, a direct action of corticosteroids on these enzymes has not been systematically investigated. Methodology & results: Corticosteroid effects on TPHs were tested using an in vitro assay. The compound with the strongest modulatory effect, beclomethasone dipropionate, activated TPH1 and TPH2 with low micromolar potency. Thermostability assays suggested a stabilizing mechanism, and computational docking indicated that beclomethasone dipropionate interacts with the TPH active site. Conclusion: Beclomethasone dipropionate is a stabilizer of TPHs, acting as a pharmacological chaperone. Our findings may inspire further development of steroid scaffolds as putative antidepressant drugs.


Assuntos
Corticosteroides/farmacologia , Triptofano Hidroxilase/metabolismo , Corticosteroides/síntese química , Corticosteroides/química , Domínio Catalítico/efeitos dos fármacos , Estabilidade Enzimática , Humanos , Conformação Molecular , Simulação de Acoplamento Molecular
2.
J Pharm Pharmacol ; 69(12): 1745-1753, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-28980320

RESUMO

OBJECTIVES: Loteprednol etabonate (LE) is the first, highly successful soft corticosteroid (SC) designed using the 'inactive metabolite' approach, starting with ∆1 -cortienic acid (d-CA). The next generation of SCs based on d-CA was etiprednol dicloacetate (ED). The 17α-dichloroacetyl function serves both as a unique pharmacophore and as the source of the molecule's softness. Highly potent SCs were designed based on a combination of ED and LE, introducing 6, 9 and 16 substituents in the molecule. METHODS: The new 6α, 9α, 16α and ß 17α-dichloroacetyl 17ß-esters were synthesized from the correspondingly substituted ∆1 -cortienic acids. The anti-inflammatory activity was assessed using LPS-induced TNF α-release under various conditions to determine intrinsic activity vs. systemic biological stability. In vivo anti-inflammatory activity was studied in the widely used ovalbumin-sensitized and ovalbumin-challenged Brown Norway rat model. KEY FINDINGS: The 6α or 9α-fluoro substitution produced highly potent corticosteroids, but the 17α-dichloroacetyl substituent provided 'softness' in all cases. Local application of these steroids will significantly reduce systemic activity, due to the facile hydrolytic deactivation of these molecules. CONCLUSIONS: A 17α-dichloroacetyl derivative of fluticasone (FLU) is highly potent but much safer than the currently used propionate or furoate ester.


Assuntos
Corticosteroides/farmacologia , Anti-Inflamatórios/farmacologia , Etabonato de Loteprednol/química , Fator de Necrose Tumoral alfa/metabolismo , Corticosteroides/síntese química , Corticosteroides/química , Animais , Anti-Inflamatórios/síntese química , Anti-Inflamatórios/química , Modelos Animais de Doenças , Fluticasona/química , Fluticasona/farmacologia , Lipopolissacarídeos/administração & dosagem , Masculino , Ovalbumina/administração & dosagem , Ratos , Ratos Endogâmicos BN , Relação Estrutura-Atividade
3.
Methods Mol Biol ; 1645: 15-27, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28710618

RESUMO

Corticosteroids are products of high industrial and commercial importance. There are dozens of different synthesis published for all of them. Some are coming from academia and some from industry. Here, industrial processes for the synthesis of prednisone, prednisolone, hydrocortisone, dexamethasone, betamethasone, and methylprednisolone are described. The starting material is diosgenin and the desired molecules are reached due to a good combination of chemistry and biotechnology that was developed along the second part of the twentieth century.


Assuntos
Corticosteroides/biossíntese , Hidrocortisona/biossíntese , Engenharia Metabólica/métodos , Sapogeninas/síntese química , Corticosteroides/síntese química , Corticosteroides/química , Hidrocortisona/química , Prednisolona/síntese química , Prednisolona/química , Prednisona/síntese química , Prednisona/química , Sapogeninas/química
4.
Arch. Soc. Esp. Oftalmol ; 90(2): 97-101, feb. 2015. ilus
Artigo em Espanhol | IBECS | ID: ibc-136614

RESUMO

CASO CLÍNICO: Mujer de 38 años con pérdida visual en ojo izquierdo y papiledema bilateral. La resonancia magnética nuclear (RMN) mostraba engrosamiento de la duramadre y la presión intracraneal estaba elevada. Se descartó enfermedad infecciosa, tumoral y autoinmune. DISCUSIÓN: La respuesta inicial a corticoides fue satisfactoria con desaparición del edema de disco óptico, mejoría de la agudeza visual y mejoría radiológica. Después de un año sin tratamiento presentó un nuevo brote, desarrollando una neuropatía óptica izquierda con pérdida irreversible de visión a pesar del retratamiento con corticoides y azatioprina


CASE REPORT: A 38-year-old female patient with bilateral papilledema who presented with loss of vision in her left eye. The Magnetic Resonance Imagining (MRI) showed thickening of the dura mater, and the intracranial pressure was elevated. A cancer, infectious, and autoimmune origin was ruled out. DISCUSSION: The initial response to high doses of corticoids was satisfactory, with disappearance of the optic disc enema, with visual acuity and an improvement in the MRI. However, after one year without treatment she had a new outbreak of the disease. Despite renewed treatment with corticoids and azathioprine, the patient developed a left optic neuropathy and irreversible visual loss


Assuntos
Humanos , Feminino , Meningite/metabolismo , Meningite/patologia , Atrofia Óptica/metabolismo , Atrofia Óptica/patologia , Corticosteroides/administração & dosagem , Corticosteroides/síntese química , Diplopia/congênito , Diplopia/patologia , Meningite/diagnóstico , Meningite/genética , Atrofia Óptica/diagnóstico , Atrofia Óptica/genética , Corticosteroides , Corticosteroides/farmacocinética , Diplopia/complicações , Diplopia/diagnóstico
5.
J Am Chem Soc ; 137(3): 1330-40, 2015 Jan 28.
Artigo em Inglês | MEDLINE | ID: mdl-25594682

RESUMO

The natural product ouabagenin is a complex cardiotonic steroid with a highly oxygenated skeleton. This full account describes the development of a concise synthesis of ouabagenin, including the evolution of synthetic strategy to access hydroxylation at the C19 position of a steroid skeleton. In addition, approaches to install the requisite butenolide moiety at the C17 position are discussed. Lastly, methodology developed in this synthesis has been applied in the generation of novel analogues of corticosteroid drugs bearing a hydroxyl group at the C19 position.


Assuntos
Corticosteroides/síntese química , Ouabaína/análogos & derivados , Corticosteroides/química , Hidroxilação , Conformação Molecular , Ouabaína/síntese química , Ouabaína/química
6.
Steroids ; 77(13): 1423-37, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22960650

RESUMO

The accurate analysis of trace components in complex biological matrices requires the use of reliable internal standards. For liquid chromatography/mass spectrometry analysis, the stable isotope-labeled analogues of the analyte molecules are the most appropriate internal standards. In this paper the synthesis of the 3- and 21-monosulfates of allo-tetrahydrocorticosteroids labeled with four or five deuterium atoms is described. The principal reactions used were (1) hydrogen-deuterium exchange reaction of active methylene groups adjacent to 3- and 11-oxo group of 17,20;20,21-bismethylenedioxy derivatives of 5α-3-ketosteroids and/or 5α-11-ketosteroids with NaOD in CH(3)OD followed by reduction with NaBD(4), (2) epimerization of the 3ß-hydroxy group into a 3α configuration, (3) sulfation of hydroxy groups at C-3 or C-21 in the resulting substrates with sulfur trioxide-trimethylamine complex, and (4) removal of 17,20;20,21-bismethylenedioxy groups with hydrogen fluoride in ethanol. Isotopic purity was found to be satisfactory by MS, and NMR properties of the new compounds were tabulated. The labeled compounds can be used as internal standards in liquid chromatography/mass spectrometry assays for clinical and biochemical studies.


Assuntos
Corticosteroides/química , Corticosteroides/síntese química , Espectrometria de Massas/normas , Sulfatos/química , Sulfatos/síntese química , Técnicas de Química Sintética , Padrões de Referência
7.
Top Curr Chem ; 311: 143-77, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-21647840

RESUMO

Bismuth(III) salts are currently considered efficient and "ecofriendly" reagents and catalysts for the development of new applications in organic synthesis. The preparation of bismuth(III) triflate and its analogues is reviewed as well as some of their applications to the synthesis of bulk chemicals via electrophilic addition and cyclization reactions. The use of bismuth(III) salts in the development of new chemical processes involving steroids and terpenes as substrates is also discussed.


Assuntos
Corticosteroides/síntese química , Bismuto/química , Terpenos/síntese química , Acilação , Ciclização , Compostos de Epóxi/química
8.
Bioorg Med Chem Lett ; 21(19): 5826-30, 2011 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-21880489

RESUMO

In this Letter we present data for a novel series of ICS for the treatment of asthma. 'Inhalation by design' principles have been applied to a series of highly potent steroidal GR agonists, with a focus on optimising the potential therapeutic index in human. Pharmacokinetic properties were tuned with high intrinsic clearance and low oral bioavailability in mind, to minimise systemic exposure and reduce systemically driven adverse events. High CYP mediated clearance as well as glucuronidation were targeted to achieve high intrinsic clearance coupled with multiple routes of clearance to minimise drug-drug interactions. Furthermore, pharmaceutical properties such as stability, crystallinity and solubility were considered to ensure compatibility with a dry powder inhaler. This work culminated in the identification of the clinical candidate 15, which demonstrates preclinically the desired efficacy and safety profiles confirming its potential as an inhaled agent for the treatment of asthma.


Assuntos
Corticosteroides/síntese química , Corticosteroides/farmacocinética , Antiasmáticos/síntese química , Antiasmáticos/farmacocinética , Asma/tratamento farmacológico , Desenho de Fármacos , Administração por Inalação , Corticosteroides/administração & dosagem , Corticosteroides/farmacologia , Agonistas Adrenérgicos beta/administração & dosagem , Agonistas Adrenérgicos beta/uso terapêutico , Androstadienos/química , Androstadienos/farmacologia , Animais , Antiasmáticos/administração & dosagem , Antiasmáticos/farmacologia , Asma/epidemiologia , Asma/fisiopatologia , Preparações de Ação Retardada , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Quimioterapia Combinada , Inaladores de Pó Seco , Fluticasona , Hepatócitos , Humanos , Fígado , Pulmão , Microssomos Hepáticos , Neutrófilos/metabolismo , Ensaios Clínicos Controlados Aleatórios como Assunto , Ratos , Fator de Necrose Tumoral alfa/biossíntese , Fator de Necrose Tumoral alfa/sangue
9.
Steroids ; 76(12): 1232-40, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21729711

RESUMO

The 3- and 21-monosulfates of pentadeuterated 5ß-tetrahydrocorticosteroides were synthesized, starting from cortisol and 11-deoxycotisol. The principal reactions used were (1) perdeuteration of the methylene groups adjacent to the 3-oxo group of 17,20:20,21-bismethylendioxy-5ß-3-ketosteroids with NaOD in CH(3)OD followed by stereoselective reduction with NaBD(4), (2) sulfation of hydroxy groups with sulfur trioxide-trimethylamine complex, and (3) removal of the 17,20:20,21-bismethylendioxy group with hydrogen fluoride. The labeled compounds can be used as internal standards in liquid chromatography/mass spectrometry assays for clinical and biochemical studies.


Assuntos
Corticosteroides/síntese química , Cetosteroides/química , Corticosteroides/química , Cromatografia Líquida/métodos , Espectrometria de Massas/métodos , Padrões de Referência
10.
São Paulo; s.n; 2010. 132 p. ilus, tab, graf.
Tese em Português | LILACS | ID: lil-595206

RESUMO

Temos mostrado que os glicocorticóides endógenos (GE) modulam o rolling e a aderência de neutrófilos in vivo, mediando a expressão de moléculas de adesão no leucócito e no endotélio. Adicionalmente, os GE controlam a maturação neutrofílica na medula e a sua mobilização para o sangue periférico. O presente trabalho visou investigar os mecanismos moleculares e celulares envolvidos na modulação exercida pelos GE neste processo. Utilizando ratos Wistar submetidos à adrenalectomia bilateral, tratados com RU 38486 ou controles (falso-operados, tratados com veículo ou não manipulados), foi demonstrado que: 1) os GE controlam, negativamente, a expressão de L-selectina em neutrófilos circulantes e ICAM-1, VCAM-1, PECAM-1, VAP-1 na célula endotelial e, positivamente, a expressão de L-selectina em granulócitos da medula óssea via seu receptor citosólico (GCR); 2) o mecanismo envolvido no controle dos GE sobre a expressão de L-selectina é independente de ação sobre sua expressão gênica ou da atividade de NFkB, mas dependente da expressão de anexina-A1, como verificado em camundongos knockouts (KO) para esta proteína 3) o controle da expressão de moléculas de adesão endotelial é dependente de ações sobre a expressão gênica, via translocação nuclear do NFkB; 4) a neutrofilia detectada em animais adrenalectomizados (ADR) é mediada pelo GCR, e dependente de anexina- A1; 5) a neutrofilia parece ser dependente da ação da anexina-A1 sobre a secreção de SDF-1 na medula óssea e expressão de CXCR-4 em neutrófilos circulantes e da medula; 6) concentrações circulantes elevadas de GE induzidas pela administração de ACTH confirmaram o controle dos GE, via anexina A-1, sobre o tráfego de neutrófilos da medula óssea para o sangue, mas sugerem um controle diferencial dos GE e anexina A-1 sobre a expressão de L-selectina em células da medula e do sangue circulante. Estes dados mostram mecanismos inéditos do controle dos GE sobre o tráfego de neutrófilos, que diferem em cada microambiente...


We have shown that endogenous glucocorticoids (GE) modulate the rolling and adhesion of neutrophils in vivo, mediating the expression of adhesion molecules on leukocytes and the endothelium. Additionally, the GE control neutrophil maturation in bone marrow and mobilization to peripheral blood. This work aimed to investigate the molecular and cellular mechanisms involved in the modulation exerted by GE in this process. Using male Wistar rats, submitted to bilateral adrenalectomy, treatment with RU 38 486 or controls (sham operated, vehicle or non manipulated), it was shown that: 1) GE control, negatively, L-selectin expression on circulating neutrophils and ICAM-1, VCAM-1, PECAM-1, VAP-1 on endothelial cell and, positively, L-selectin expression on bone marrow granulocytes via their cytosolic receptor (GCR); 2) the mechanism involved in the control of GE on the L-selectin expression is independent of its action on gene expression or NFkB activity, but dependent on the expression of anexina-A1, as observed in mice knockouts for this protein; 3) the control of endothelial adhesion molecules is dependent on gene expression, via NFkB translocation; 4) the neutrophilia detected in adrenalectomized animals (ADR) is mediated by GCR, and dependent on anexina-A1; 5) the neutrophilia seems to be dependent on the action of annexin A-1 on SDF-1á secretion in bone marrow and expression of CXCR-4 in peripheral blood and bone marrow; 6) high circulating concentrations of GE induced by administration of ACTH confirmed the control of GE, via the annexin-1, on the traffic of neutrophils from the bone marrow to the blood, but suggest a differential control of GE and annexin A-1 on the L-selectin expression in the bone marrow and circulating blood. These data indicate unpublished mechanisms of control of GE on the traffic of neutrophils, which differ in each microenvironment and cell type involved in this complex phenomenon.


Assuntos
Animais , Masculino , Adulto Jovem , Ratos , Fenômenos Fisiológicos Celulares , Corticosteroides/síntese química , Glicóis/síntese química , Moléculas de Adesão Celular/farmacologia , Neutrófilos , Capacidade de Resposta ante Emergências , Leucócitos , Farmacologia , Fisiologia
11.
Steroids ; 74(10-11): 870-5, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19538978

RESUMO

Despite the important physiological role of the corticosteroids glucuronides, very poor NMR data for this class of compounds are reported. For this reason we prepared a set of corticosteroids and submitted them to a detailed NMR study. A complete assignment of (1)H and (13)C signals was accomplished arranging mono- and two-dimensional NMR techniques.


Assuntos
Corticosteroides/química , Corticosteroides/síntese química , Glucuronídeos/química , Glucuronídeos/síntese química , Espectroscopia de Ressonância Magnética , Espectrometria de Massas
12.
Curr Pharm Des ; 12(25): 3241-60, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-17020532

RESUMO

Inhaled and intranasal corticosteroids (ICSs) still are the most effective treatment available for allergic airway diseases and are likely to remain the cornerstone of managing persistent asthma/allergic rhinitis in the foreseeable future. Even if the therapeutic index of this class increased significantly with the introduction of newer corticosteroids, and even if new therapeutic potentials are beginning to emerge with our increasing understanding of the mechanisms of asthma, chronic obstructive pulmonary disease, and rhinitis, corticosteroid development still remains a very important field for drug designers. After a brief review of issues related to the structure-activity relationships of glucocorticoids and the main determinants of their receptor-binding affinity at the glucocorticoid receptor, the main focus of the present article will be on the development of soft corticosteroids, as they are particularly well suited to separate local activity from systemic side effects, which still is an important issue for ICSs. Design consideration required in the search for safe and effective soft drugs on one hand, and safe and effective ICSs on the other hand, will be briefly discussed and illustrated with a number of cases, in particular, with that of loteprednol etabonate and etiprednol dicloacetate, soft corticosteroids that are being developed for a full spectrum of therapeutic applications including asthma and allergic rhinitis.


Assuntos
Corticosteroides/síntese química , Corticosteroides/uso terapêutico , Asma/tratamento farmacológico , Desenho de Fármacos , Corticosteroides/farmacocinética , Animais , Antiasmáticos/síntese química , Antiasmáticos/farmacocinética , Antiasmáticos/uso terapêutico , Asma/metabolismo , Humanos , Relação Estrutura-Atividade
13.
Bioorg Med Chem Lett ; 16(13): 3454-8, 2006 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-16644222

RESUMO

Fluoropyridyl derivatives of [3,2-c]pyrazolo-corticosteroids have high affinity for the glucocorticoid receptor (GR) and are highly active glucocorticoids. They are thus considered to be excellent candidates for PET imaging of GR containing tissues when labeled with fluorine-18 (t(1/2)=110 min). Previously reported syntheses of these fluorinated glucocorticoids were accomplished by conventional thermal nucleophilic halogen exchange reactions with chloropyridyl precursors. These reactions were found to proceed at rates too slow for feasible application to radiosynthesis using [(18)F]fluoride. We have applied microwave-heating methods to these reactions and found that significant rate enhancements can be realized. Kinetic experiments showed an average relative rate ratio of 3/1 for microwave versus conventional heating and preparative experiments showed an average relative conversion ratio of 4.5/1 during the initial 120 min, a period approximating one half-life of the isotope. The microwave method described was used to prepare previously unreported 2'-(2-fluoro-4-pyridyl)-11beta,17,21-trihydroxy-16alpha-methyl-20-oxo-pregn-4-eno-[3,2-c]-pyrazole, which was evaluated for biological activity.


Assuntos
Corticosteroides/síntese química , Flúor/química , Pregnenos/síntese química , Pirazóis/síntese química , Piridinas/química , Receptores de Glucocorticoides/efeitos dos fármacos , Corticosteroides/farmacologia , Corticosteroides/efeitos da radiação , Glucocorticoides/química , Glucocorticoides/metabolismo , Cinética , Micro-Ondas , Estrutura Molecular , Tomografia por Emissão de Pósitrons/métodos , Pregnenos/química , Pregnenos/farmacologia , Pirazóis/química , Pirazóis/farmacologia , Pirazóis/efeitos da radiação , Piridinas/efeitos da radiação , Receptores de Glucocorticoides/metabolismo , Sensibilidade e Especificidade , Estereoisomerismo , Relação Estrutura-Atividade
14.
Rev. SOCERJ ; 18(6): 510-515, nov.-dez. 2005. graf
Artigo em Português | LILACS | ID: lil-434755

RESUMO

Na busca da melhor compreensão da origem das doenças cardiovasculares, uma importante linha de investigação surgiu a partir da demonstração da associação entre o baixo peso ao nascer e o desenvolvimento de hipertensão foi a base para a formulação da hipótese de que doenças cardiovasculares manifestadas na idade adulta podem ser programadas a partir de insultos ocorridos no período pré natal.Diversos modelos experimentais apóiam esta teoria. Em animais de laboratório, estudos com desnutrição induzida durante a gestação resultaram em animais adultos com níveis mais elevados de pressão arterial do que os controles...


Assuntos
Cuidado Pré-Natal/métodos , Cuidado Pré-Natal/tendências , Hipertensão/diagnóstico , Hipertensão/fisiopatologia , Hipertensão/terapia , Insuficiência Placentária/diagnóstico , Insuficiência Placentária/terapia , Corticosteroides/fisiologia , Corticosteroides/síntese química , Renina/fisiologia , Renina/síntese química
15.
Int J Pharm ; 263(1-2): 69-83, 2003 Sep 16.
Artigo em Inglês | MEDLINE | ID: mdl-12954182

RESUMO

Polymeric drug-containing nanoparticles were prepared using a novel aerosol flow reactor method. The polymeric drug-containing nanoparticles prepared consist of a poorly water soluble corticosteroid, beclomethasone dipropionate, and polymeric materials Eudragit E 100 or Eudragit L 100. The novel method used in this study allows synthesis of nanoparticles directly as dry powders. The nanoparticles can contain various ratios of drug and polymer, and the use of any additional stabilisation materials is avoided. In this study, nanoparticles with different drug-to-polymer ratios were prepared. Particle size and morphology, crystallinity, and thermal behaviour were determined as a function of particle composition. It was found that all the nanoparticles produced, regardless of particle composition, had geometric number mean diameters of approximately 90 nm, and were spherical showing smooth surfaces. The drug was molecularly dispersed in the amorphous polymeric matrix of the nanoparticles, and drug crystallisation was not observed when the ambient temperature was below the glass transition temperature of the polymer.


Assuntos
Corticosteroides/síntese química , Aerossóis/síntese química , Nanotecnologia/métodos , Polímeros/síntese química , Tecnologia Farmacêutica/métodos , Corticosteroides/análise , Aerossóis/análise , Polímeros/análise , Tecnologia Farmacêutica/instrumentação
16.
Steroids ; 68(2): 177-91, 2003 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-12606009

RESUMO

Corticosteroids regulate a variety of essential physiological functions, such as mineral balance and stress. The great interest in these steroids, especially the glucocorticoids, stems from roles they are thought to play in neuropsychiatric disorders, such as severe depression and anxiety.The development of glucocorticoid receptor (GR) ligands which are appropriately labeled with short-lived positron-emitting radioisotopes would allow the non-invasive in-vivo imaging and mapping of brain GRs by means of positron emission tomography (PET). In this context we have synthesized a series of novel arylpyrazolo steroids exhibiting different substitution patterns at the D-ring of the steroid skeleton, as ligands for brain GRs. Special attention was given to 4-fluorophenyl pyrazolo steroids, which are known to display high binding affinity toward the GR. The compounds were evaluated in a competitive radiometric receptor binding assay to determine their relative binding affinities (RBA) to the GR. Some compounds show good binding affinities of up to 56% in comparison to dexamethasone (100%). In initial experiments, selected candidates were labeled with the positron emitter fluorine-18 and in one case with the gamma-emitter iodine-131.


Assuntos
Corticosteroides/síntese química , Corticosteroides/metabolismo , Encéfalo/metabolismo , Pirazóis/síntese química , Pirazóis/metabolismo , Receptores de Glucocorticoides/metabolismo , Corticosteroides/química , Ligação Competitiva , Radioisótopos de Flúor , Ligantes , Estrutura Molecular , Pirazóis/química , Receptores de Glucocorticoides/análise , Tomografia Computadorizada de Emissão
17.
Steroids ; 67(7): 549-54, 2002 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11996925

RESUMO

Two new C-nor/D-homo corticosteroids were isolated from the filtrate of the triene carbonate intermediate during the production of betamethasone. Their structures were elucidated based on NMR spectroscopic studies and mass spectral analyses. The mechanism of formation of each of these two steroids was postulated as a Wagner-Meerwein rearrangement of the corresponding 12beta-hydroxy steroid. The new 12beta-hydroxy corticosteroid was also isolated from the fermentation process of betamethasone synthesis. Its structure was identified via NMR and mass spectroscopic studies. Treatment of the new 12beta-hydroxy corticoid with PCl(5) at low temperature provided two C-nor/D-homo compounds in a ratio of 1:1. Conversion of 12beta-hydroxy corticoid into a corresponding 12beta-mesylate followed by heating in HOAc to 110 degrees C in the presence of NaOAc produced a mixture of the rearranged products in a 1:4 ratio.


Assuntos
Corticosteroides/química , Corticosteroides/síntese química , Betametasona/análogos & derivados , Betametasona/química , Corticosteroides/isolamento & purificação , Espectroscopia de Ressonância Magnética , Estrutura Molecular
18.
Clín. investig. ginecol. obstet. (Ed. impr.) ; 27(6): 212-233, jun. 2000. tab
Artigo em Es | IBECS | ID: ibc-20943

RESUMO

Desde los trabajos de Liggins y Howie (1972), numerosos estudios han demostrado que la corticoterapia antenatal permite disminuir la mortalidad y la morbilidad perinatal de manera muy significativa. Esta terapia parece carecer de peligro, tanto para la madre como para el niño, y debería ser administrada cada vez que un parto prematuro tiene posibilidades de supervivencia. La existencia de un parto inminente, de una rotura prematura de membranas o de una edad gestacional superior a 34 semanas de amenorrea no son obstáculos al tratamiento, puesto que incluso en estas situaciones, tiene una eficacia real. Más de la mitad de los niños nacidos prematuramente deberían teóricamente de haberse beneficiado de una corticoterapia durante el período antenatal, mientras que la cifra real es probablemente inferior al 20 por ciento. La relación coste-eficacia de esta política sería extremadamente positiva: más de 1.500 muertes neonatales anuales podrían ser evitadas, acompañándose de una economía del 10 por ciento en el cuidado de los recién nacidos (AU)


Assuntos
Adulto , Gravidez , Feminino , Lactente , Masculino , Humanos , Recém-Nascido , Corticosteroides/administração & dosagem , Corticosteroides/análise , Corticosteroides/efeitos adversos , Fosfatidilcolinas/administração & dosagem , Fosfatidilcolinas/análise , Esfingomielinas/administração & dosagem , Esfingomielinas/análise , Glândulas Suprarrenais/patologia , Retardo do Crescimento Fetal/complicações , Prostaglandinas/metabolismo , Manifestações Neurológicas , Enterocolite Pseudomembranosa/complicações , Edema Pulmonar/complicações , Complicações na Gravidez/tratamento farmacológico , Ensaios Clínicos Controlados Aleatórios como Assunto/métodos , Diferenciação Celular/genética , Diferenciação Celular/fisiologia , Corticosteroides/agonistas , Corticosteroides/antagonistas & inibidores , Corticosteroides , Corticosteroides/farmacocinética , Corticosteroides/metabolismo , Corticosteroides/síntese química , Teratogênicos/análise , Gravidez Múltipla , Gravidez em Diabéticas/complicações , Gravidez em Diabéticas/tratamento farmacológico
19.
J Med Chem ; 37(22): 3717-29, 1994 Oct 28.
Artigo em Inglês | MEDLINE | ID: mdl-7966132

RESUMO

The preparation and topical antiinflammatory potencies of a series of halomethyl 17 alpha-(acyloxy)- 11 beta-hydroxy-3-oxoandrosta-1,4-diene-17 beta-carbothioates, carrying combinations of 6 alpha-fluoro, 9 alpha-fluoro, 16-methyl, and 16-methylene substituents, are described. Key synthetic stages were the preparation of carbothioic acids and their reaction with dihalomethanes. The carbothioic acids were formed from 17 beta-carboxylic acids by initial reaction with dimethylthiocarbamoyl chloride followed by aminolysis of the resulting rearranged mixed anhydride with diethylamine, or by carboxyl activation with 1,1'-carbonyldiimidazole (CDI) or 2-fluoro-N-methylpyridinium tosylate (FMPT) and reaction with hydrogen sulfide, the choice of reagent being governed by the 17 alpha-substituent. Carboxyl activation with FMPT and reaction with sodium hydrogen selenide led to the halomethyl 16-methyleneandrostane-17 beta-carboselenoate analogues. Anti-inflammatory potencies were measured in humans using the vasoconstriction assay and in rats and mice by a modification the Tonelli croton oil ear assay. Best activities were shown by fluoromethyl and chloromethyl carbothioates with a 17 alpha-propionyloxy group. S-Fluoromethyl 6 alpha, 9 alpha-difluoro-11 beta-hydroxy-16 alpha-methyl-3-oxo-17 alpha- (propionyloxy)androsta-1,4-diene-17 beta-carbothioate (fluticasone propionate, FP) was selected for clinical study as it showed high topical antiinflammatory activity but caused little hypothalamic-pituitary-adrenal suppression after topical or oral administration to rodents.


Assuntos
Corticosteroides/síntese química , Corticosteroides/farmacologia , Androstanos/síntese química , Anti-Inflamatórios/síntese química , Anti-Inflamatórios/farmacologia , Glândulas Suprarrenais/efeitos dos fármacos , Androstanos/farmacologia , Animais , Feminino , Humanos , Sistema Hipotálamo-Hipofisário/efeitos dos fármacos , Espectroscopia de Ressonância Magnética , Masculino , Camundongos , Ratos , Relação Estrutura-Atividade
20.
J Pharm Biomed Anal ; 12(6): 805-10, 1994 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-7918783

RESUMO

A study of a multiple high-performance liquid chromatographic procedure for the separation of 30 different corticosteroids is described. Normal- and reversed-phase general methods operating in a wide polarity range have been developed for the rapid screening of multicomponent mixtures. The complementary application of both normal- and reversed-phase methods could permit clarification of uncertainty deriving from analyses performed by only one method.


Assuntos
Corticosteroides/análise , Cromatografia Líquida de Alta Pressão/métodos , Corticosteroides/síntese química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...